Cargando…
Development of a novel Ara h 2 hypoallergen with no IgE binding or anaphylactogenic activity
BACKGROUND: To date, no safe allergen-specific immunotherapy for patients with peanut allergy is available. Previous trials were associated with severe side effects. OBJECTIVE: We sought to determine the relative importance of conformational and linear IgE-binding epitopes of the major peanut allerg...
Autores principales: | Tscheppe, Angelika, Palmberger, Dieter, van Rijt, Leonie, Kalic, Tanja, Mayr, Vanessa, Palladino, Chiara, Kitzmüller, Claudia, Hemmer, Wolfgang, Hafner, Christine, Bublin, Merima, van Ree, Ronald, Grabherr, Reingard, Radauer, Christian, Breiteneder, Heimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7100897/ https://www.ncbi.nlm.nih.gov/pubmed/31525384 http://dx.doi.org/10.1016/j.jaci.2019.08.036 |
Ejemplares similares
-
Peanut lipids influence the response of bronchial epithelial cells to the peanut allergens Ara h 1 and Ara h 2 by decreasing barrier permeability
por: Palladino, Chiara, et al.
Publicado: (2023) -
The Major Peanut Allergen Ara h 2 Produced in Nicotiana benthamiana Contains Hydroxyprolines and Is a Viable Alternative to the E. Coli Product in Allergy Diagnosis
por: Üzülmez, Öykü, et al.
Publicado: (2021) -
Atopic donor status does not influence the uptake of the major grass pollen allergen, Phl p 5, by dendritic cells
por: Ashjaei, Kazem, et al.
Publicado: (2015) -
Fish-derived low molecular weight components modify bronchial epithelial barrier properties and release of pro-inflammatory cytokines
por: Kalic, Tanja, et al.
Publicado: (2019) -
Chimeras of Bet v 1 and Api g 1 reveal heterogeneous IgE responses in patients with birch pollen allergy
por: Gepp, Barbara, et al.
Publicado: (2014)